시장조사 보고서 : 세계의 화농성한선염 치료 시장예측 2021년-2026년

■ 영문 제목 : Global Hidradenitis Suppurativa Treatment Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00884 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 101 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 서비스

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 화농성한선염 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (약물, 외과, 기타)와 용도별 시장규모 (병원, 클리닉, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 화농성한선염 치료 시장 점유율
- 지역별 화농성한선염 치료 시장규모
- 주요지역의 종류별 시장규모 (약물, 외과, 기타)
- 주요지역의 용도별 시장규모 (병원, 클리닉, 기타)
- 미주의 화농성한선염 치료 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 화농성한선염 치료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 화농성한선염 치료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 화농성한선염 치료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 화농성한선염 치료 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
AbbVie, Merck, Pfizer, AstraZeneca, GlaxoSmithKline, Perrigo, Sun Pharma, Almirall, Bausch Health, Johnson & Johnson
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Hidradenitis Suppurativa Treatment will have significant change from previous year. By the most conservative estimates of global Hidradenitis Suppurativa Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 605.3 million in 2020. Over the next five years the Hidradenitis Suppurativa Treatment market will register a 4.4% CAGR in terms of revenue, the global market size will reach US$ 717.9 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Hidradenitis Suppurativa Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Medications
Surgery
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
Merck
Pfizer
AstraZeneca
GlaxoSmithKline
Perrigo
Sun Pharma
Almirall
Bausch Health
Johnson & Johnson

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hidradenitis Suppurativa Treatment Market Size 2016-2026
2.1.2 Hidradenitis Suppurativa Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Hidradenitis Suppurativa Treatment Segment by Type
2.2.1 Medications
2.2.2 Medications
2.2.3 Others
2.3 Hidradenitis Suppurativa Treatment Market Size by Type
2.3.1 Global Hidradenitis Suppurativa Treatment Market Size CAGR by Type
2.3.2 Global Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
2.4 Hidradenitis Suppurativa Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Hidradenitis Suppurativa Treatment Market Size by Application
2.5.1 Global Hidradenitis Suppurativa Treatment Market Size CAGR by Application
2.5.2 Global Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)

3 Hidradenitis Suppurativa Treatment Market Size by Players
3.1 Hidradenitis Suppurativa Treatment Market Size Market Share by Players
3.1.1 Global Hidradenitis Suppurativa Treatment Revenue by Players (2019-2021E)
3.1.2 Global Hidradenitis Suppurativa Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Hidradenitis Suppurativa Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Hidradenitis Suppurativa Treatment by Regions
4.1 Hidradenitis Suppurativa Treatment Market Size by Regions (2016-2021)
4.2 Americas Hidradenitis Suppurativa Treatment Market Size Growth (2016-2021)
4.3 APAC Hidradenitis Suppurativa Treatment Market Size Growth (2016-2021)
4.4 Europe Hidradenitis Suppurativa Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Growth (2016-2021)

5 Americas
5.1 Americas Hidradenitis Suppurativa Treatment Market Size by Country (2016-2021)
5.2 Americas Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021)
5.3 Americas Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Hidradenitis Suppurativa Treatment Market Size by Region (2016-2021)
6.2 APAC Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021)
6.3 APAC Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Hidradenitis Suppurativa Treatment by Country (2016-2021)
7.2 Europe Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021)
7.3 Europe Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Hidradenitis Suppurativa Treatment by Region (2016-2021)
8.2 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Hidradenitis Suppurativa Treatment Market Forecast
10.1 Global Hidradenitis Suppurativa Treatment Forecast by Regions (2021-2026)
10.1.1 Global Hidradenitis Suppurativa Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Hidradenitis Suppurativa Treatment Forecast
10.1.3 APAC Hidradenitis Suppurativa Treatment Forecast
10.1.4 Europe Hidradenitis Suppurativa Treatment Forecast
10.1.5 Middle East & Africa Hidradenitis Suppurativa Treatment Forecast
10.2 Americas Hidradenitis Suppurativa Treatment Forecast by Countries (2021-2026)
10.2.1 United States Hidradenitis Suppurativa Treatment Market Forecast
10.2.2 Canada Hidradenitis Suppurativa Treatment Market Forecast
10.2.3 Mexico Hidradenitis Suppurativa Treatment Market Forecast
10.2.4 Brazil Hidradenitis Suppurativa Treatment Market Forecast
10.3 APAC Hidradenitis Suppurativa Treatment Forecast by Region (2021-2026)
10.3.1 China Hidradenitis Suppurativa Treatment Market Forecast
10.3.2 Japan Hidradenitis Suppurativa Treatment Market Forecast
10.3.3 Korea Hidradenitis Suppurativa Treatment Market Forecast
10.3.4 Southeast Asia Hidradenitis Suppurativa Treatment Market Forecast
10.3.5 India Hidradenitis Suppurativa Treatment Market Forecast
10.3.6 Australia Hidradenitis Suppurativa Treatment Market Forecast
10.4 Europe Hidradenitis Suppurativa Treatment Forecast by Country (2021-2026)
10.4.1 Germany Hidradenitis Suppurativa Treatment Market Forecast
10.4.2 France Hidradenitis Suppurativa Treatment Market Forecast
10.4.3 UK Hidradenitis Suppurativa Treatment Market Forecast
10.4.4 Italy Hidradenitis Suppurativa Treatment Market Forecast
10.4.5 Russia Hidradenitis Suppurativa Treatment Market Forecast
10.5 Middle East & Africa Hidradenitis Suppurativa Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Hidradenitis Suppurativa Treatment Market Forecast
10.5.2 South Africa Hidradenitis Suppurativa Treatment Market Forecast
10.5.3 Israel Hidradenitis Suppurativa Treatment Market Forecast
10.5.4 Turkey Hidradenitis Suppurativa Treatment Market Forecast
10.5.5 GCC Countries Hidradenitis Suppurativa Treatment Market Forecast
10.6 Global Hidradenitis Suppurativa Treatment Forecast by Type (2021-2026)
10.7 Global Hidradenitis Suppurativa Treatment Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Hidradenitis Suppurativa Treatment Product Offered
11.1.3 AbbVie Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Hidradenitis Suppurativa Treatment Product Offered
11.2.3 Merck Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Merck Main Business Overview
11.2.5 Merck Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Hidradenitis Suppurativa Treatment Product Offered
11.3.3 Pfizer Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Hidradenitis Suppurativa Treatment Product Offered
11.4.3 AstraZeneca Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Hidradenitis Suppurativa Treatment Product Offered
11.5.3 GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Perrigo
11.6.1 Perrigo Company Information
11.6.2 Perrigo Hidradenitis Suppurativa Treatment Product Offered
11.6.3 Perrigo Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Perrigo Main Business Overview
11.6.5 Perrigo Latest Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Information
11.7.2 Sun Pharma Hidradenitis Suppurativa Treatment Product Offered
11.7.3 Sun Pharma Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Sun Pharma Main Business Overview
11.7.5 Sun Pharma Latest Developments
11.8 Almirall
11.8.1 Almirall Company Information
11.8.2 Almirall Hidradenitis Suppurativa Treatment Product Offered
11.8.3 Almirall Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Almirall Main Business Overview
11.8.5 Almirall Latest Developments
11.9 Bausch Health
11.9.1 Bausch Health Company Information
11.9.2 Bausch Health Hidradenitis Suppurativa Treatment Product Offered
11.9.3 Bausch Health Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Bausch Health Main Business Overview
11.9.5 Bausch Health Latest Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Information
11.10.2 Johnson & Johnson Hidradenitis Suppurativa Treatment Product Offered
11.10.3 Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Johnson & Johnson Main Business Overview
11.10.5 Johnson & Johnson Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Hidradenitis Suppurativa Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Medications
Table 3. Major Players of Surgery
Table 4. Major Players of Others
Table 5. Hidradenitis Suppurativa Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
Table 8. Hidradenitis Suppurativa Treatment Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 9. Global Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 10. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)
Table 11. Global Hidradenitis Suppurativa Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Players (2019-2021E)
Table 13. Hidradenitis Suppurativa Treatment Key Players Head office and Products Offered
Table 14. Hidradenitis Suppurativa Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hidradenitis Suppurativa Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Regions 2016-2021
Table 19. Americas Hidradenitis Suppurativa Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Country (2016-2021)
Table 21. Americas Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
Table 23. Americas Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 24. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)
Table 25. APAC Hidradenitis Suppurativa Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Region (2016-2021)
Table 27. APAC Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
Table 29. APAC Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 30. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)
Table 31. Europe Hidradenitis Suppurativa Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Country (2016-2021)
Table 33. Europe Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
Table 35. Europe Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 36. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)
Table 37. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size by Application (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Application (2016-2021)
Table 43. Key and Potential Regions of Hidradenitis Suppurativa Treatment
Table 44. Key Application and Potential Industries of Hidradenitis Suppurativa Treatment
Table 45. Key Challenges of Hidradenitis Suppurativa Treatment
Table 46. Key Trends of Hidradenitis Suppurativa Treatment
Table 47. Global Hidradenitis Suppurativa Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Hidradenitis Suppurativa Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Hidradenitis Suppurativa Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Hidradenitis Suppurativa Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Hidradenitis Suppurativa Treatment Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 52. Global Hidradenitis Suppurativa Treatment Market Size Market Share Forecast by Application (2021-2026)
Table 53. AbbVie Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 54. AbbVie Hidradenitis Suppurativa Treatment Product Offered
Table 55. AbbVie Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Merck Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 59. Merck Hidradenitis Suppurativa Treatment Product Offered
Table 60. Merck Main Business
Table 61. Merck Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Merck Latest Developments
Table 63. Pfizer Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 64. Pfizer Hidradenitis Suppurativa Treatment Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. Pfizer Latest Developments
Table 68. AstraZeneca Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 69. AstraZeneca Hidradenitis Suppurativa Treatment Product Offered
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. AstraZeneca Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 74. GlaxoSmithKline Hidradenitis Suppurativa Treatment Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. GlaxoSmithKline Latest Developments
Table 78. Perrigo Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 79. Perrigo Hidradenitis Suppurativa Treatment Product Offered
Table 80. Perrigo Main Business
Table 81. Perrigo Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Perrigo Latest Developments
Table 83. Sun Pharma Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 84. Sun Pharma Hidradenitis Suppurativa Treatment Product Offered
Table 85. Sun Pharma Main Business
Table 86. Sun Pharma Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Sun Pharma Latest Developments
Table 88. Almirall Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 89. Almirall Hidradenitis Suppurativa Treatment Product Offered
Table 90. Almirall Main Business
Table 91. Almirall Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Almirall Latest Developments
Table 93. Bausch Health Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 94. Bausch Health Hidradenitis Suppurativa Treatment Product Offered
Table 95. Bausch Health Main Business
Table 96. Bausch Health Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Bausch Health Latest Developments
Table 98. Johnson & Johnson Details, Company Type, Hidradenitis Suppurativa Treatment Area Served and Its Competitors
Table 99. Johnson & Johnson Hidradenitis Suppurativa Treatment Product Offered
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Hidradenitis Suppurativa Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Hidradenitis Suppurativa Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hidradenitis Suppurativa Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Type in 2020
Figure 7. Hidradenitis Suppurativa Treatment in Hospitals
Figure 8. Global Hidradenitis Suppurativa Treatment Market: Hospitals (2016-2021) & ($ Millions)
Figure 9. Hidradenitis Suppurativa Treatment in Clinics
Figure 10. Global Hidradenitis Suppurativa Treatment Market: Clinics (2016-2021) & ($ Millions)
Figure 11. Hidradenitis Suppurativa Treatment in Others
Figure 12. Global Hidradenitis Suppurativa Treatment Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Application in 2020
Figure 14. Global Hidradenitis Suppurativa Treatment Revenue Market Share by Player in 2020
Figure 15. Global Hidradenitis Suppurativa Treatment Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Hidradenitis Suppurativa Treatment Market Size 2016-2021 ($ Millions)
Figure 17. APAC Hidradenitis Suppurativa Treatment Market Size 2016-2021 ($ Millions)
Figure 18. Europe Hidradenitis Suppurativa Treatment Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size 2016-2021 ($ Millions)
Figure 20. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Country in 2020
Figure 21. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Type in 2020
Figure 22. Americas Hidradenitis Suppurativa Treatment Market Size Market Share by Application in 2020
Figure 23. United States Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Regions in 2020
Figure 27. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Type in 2020
Figure 28. APAC Hidradenitis Suppurativa Treatment Market Size Market Share by Application in 2020
Figure 29. China Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Country in 2020
Figure 36. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Type in 2020
Figure 37. Europe Hidradenitis Suppurativa Treatment Market Size Market Share by Application in 2020
Figure 38. Germany Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size Market Share by Application in 2020
Figure 46. Egypt Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Hidradenitis Suppurativa Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 52. APAC Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 53. Europe Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 55. United States Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 56. Canada Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 59. China Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 60. Japan Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 61. Korea Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 63. India Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 64. Australia Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 65. Germany Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 66. France Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 67. UK Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Italy Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 69. Russia Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Spain Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 73. Israel Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Hidradenitis Suppurativa Treatment Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 화농성한선염 치료 시장예측 2021년-2026년] (코드 : LPI-2201K00884) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 화농성한선염 치료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 과민성 방광 치료 시장예측 2021년-2026년
LPI-2201K02444 / LP Information / 2021년 12월 / 본 조사보고서는 과민성 방광 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Overactive Bladder Treatment will have significant change from previous year. By the most conservative estimates of global Overactive Bladder Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 4901 million in...

세계의 전이성 암 치료 시장예측 2021년-2026년
LPI-2201K02228 / LP Information / 2021년 12월 / 본 조사보고서는 전이성 암 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Metastatic Cancer Treatment will have significant change from previous year. By the most conservative estimates of global Metastatic Cancer Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 49140 million in...

세계의 패혈증 치료 시장예측 2021년-2026년
LPI-2201K02174 / LP Information / 2021년 12월 / 본 조사보고서는 패혈증 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Sepsis Treatment will have significant change from previous year. By the most conservative estimates of global Sepsis Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3072.3 million in 2020. Over...

세계의 원시 치료 시장예측 2021년-2026년
LPI-2201K00142 / LP Information / 2021년 12월 / 본 조사보고서는 원시 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Hypermetropia Treatment will have significant change from previous year. By the most conservative estimates of global Hypermetropia Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 마비 치료 시장예측 2021년-2026년
LPI-2201K02258 / LP Information / 2021년 12월 / 본 조사보고서는 마비 치료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Paralysis (Plegia) Treatment will have significant change from previous year. By the most conservative estimates of global Paralysis (Plegia) Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...